Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

BIO 2013 Monday Roundup: Bayer, Orphan Drug Pricing, Avalon/GSK

Apr 23 2013

• By Wendy Diller, Alex Lash, and Chris Morrison

Related Content

GSK Will Be A Limited Partner In Sanderling Ventures’ New Fund

Jan 10 2013

Top Changes At Bayer And Novartis As Vasella Goes, Reinhardt Returns

Jan 28 2013

Avalon's Sweat Equity

Mar 01 2011

Cancer Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind

Nov 07 2011

Related Companies

Bayer AG

Vertex Pharmaceuticals Incorporated

Cystic Fibrosis Foundation

AbbVie Inc.

Additional Topics

United States Business Strategies Innovation BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window